Jul 27, 2023 / 12:00PM GMT
Operator
Thank you for standing by, and welcome to the Krystal Biotech R&D Oncology Program Announcement Investor Conference Call. As a reminder, today's conference is being recorded.
I would now like to hand the conference over to your host, Meg Dodge, Head of Investor Relations and Corporate Communications. Please begin.
Meg Dodge - Krystal Biotech, Inc. - VP of IR & Corporate Communications
Hello, and thank you for joining us today for the announcement of Krystal's Oncology Program. Joining us today from Krystal is Chairman and Chief Executive Officer, Krish Krishnan; Co-Founder and President of Research and Development, Suma Krishnan; Dr. Samuel Broder, Former Director of the National Cancer Institute; Dr. David Chien, Senior Vice President of Clinical Development; and Dr. Trevor Parry, Vice President of Research and Scientific Affairs at Krystal.
Also with us on the call is Dr. Jason Luke, Associate Professor of Medicine in the Division of Hematology/Oncology and Director of the Cancer Immunotherapeutic Center within the University of
Krystal Biotech Inc Research & Development Oncology Program Announcement Call Transcript
Jul 27, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers